Abstract
Cafe-au-lait macules (CALMs) affect the appearance of patients and can result in serious psychological problems. Successful treatments without adverse effects remain challenging. We designed a prospective, randomized, controlled, evaluator-blinded trial on 40 pediatric patients to compare the efficacy between a low-fluence 1064-nm Q-switched Nd:YAG laser and a Q-switched Nd:YAG 532-nm laser for the treatment of solitary CALMs in children. We randomly assigned participants into 2 groups. We treated those in the first group with 3 sessions of 532-nm QS laser at 1-month intervals, and those in the second group with 6 sessions of 1064-nm LFQS laser at 2-week intervals. We found no significant differences in treatment efficacy (p = 0.14). The 1064-nm laser group referred significantly less pain than the 532-nm laser group (p = 0.0001). Side effects were detected in 5 patients in the 532-nm laser group. The difference of the side effects was statistically significant (p = 0.04). Two patients in 532-nm laser group were recurred and none in 1064-nm laser group. On a univariate logistic regression analysis, lesions with brown color, small size, and irregular edges were significantly associated with better outcomes (> 50% clearance). Multivariate logistic regression analysis found that brown lesions and lesions with irregular edges had higher odds of getting > 50% clearance (p < 0.05). In conclusion, the 1064-nm LFQS laser produced fewer side effects, less pain, and shorter recovery time than the 532-nm laser. Irregular-bordered, smaller, brown lesions improved better than smooth-bordered, larger, light brown lesions. Moreover, the 1064-nm laser may be a better choice for treating large size CALMs. However, no significant differences were found in terms of the treatment efficacy and recurrence.
Similar content being viewed by others
References
Belkin DA, Neckman JP, Jeon H, Friedman P, Geronemus RG (2017) Response to laser treatment of café au lait macules based on morphologic features. JAMA Dermatol 153(11):1158–1161
Baek JO, Park IJ, Lee KR, Ryu HR, Kim J, Lee S, Kim YR, Hur H (2018) High-fluence 1064-nm Q-Switched Nd:YAG laser: safe and effective treatment of café-au-lait macules in Asian patients. J Cosmet Dermatol 17(3):380–384
Artzi O, Mehrabi JN, Koren A, Niv R, Lapidoth M, Levi A (2018) Picosecond 532-nm neodymium-doped yttrium aluminium garnet laser-a novel and promisingmodality for the treatment of café-au-lait macules. Lasers Med Sci 33(4):693–697
Lin Y, Liu HX, Shi WH, Wang HX, Geng JH, Guo X, Wang JL, Zhang FR (2019) Preliminary experience ofthe Q-switched 1064-nm neodymium:yttrium aluminum garnet laser in the treatment of Café-au-lait macules. J Eur Acad Dermatol Venereol 33(4):e185–e186
Balaraman B, Ravanfar-Jordan P, Friedman PM (2017) Novel use of non-ablative fractionalphotothermolysis for cafe-au-lait macules in darker skin types. Lasers Surg Med 49(1):84–87
Levy JLMS, Pizzi-Anselme M (1999) Treatment of individual cafe au lait macules with the Q-switched Nd:YAG: a clinicpathologic correlation. J Cutan Laser Ther 1(4):217–223
Kim JS, Kim MJ, Cho SB (2009) Treatment of segmental cafe-au-lait macules using 1064-nm Q-switched Nd:YAG laser with low pulse energy. Clin Exp Dermatol 34(7):e223–e224
Kim HR, Ha JM, Park MS, Lee Y, Seo YJ, Kim CD et al (2015) A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminium garnet laser for the treatment of cafe-au-lait macules. J Am Acad Dermatol 73(3):477–483
Won KH, Lee YJ, Rhee do Y, Chang SE (2016) Fractional 532-nm Q-switched Nd:YAGlaser: one of the safest novel treatment modality to treat cafe-au-lait macules. J Cosmet Laser Ther 18(5):268–269
Downs AM, Rickard A, Palmer J (2004) Laser treatment of benignpigmented lesions in children: effective long-term benefits of the Q-switched frequency-doubled Nd:YAG and long-pulsedalexandrite lasers. Pediatr Dermatol 21:88–90
Polder KD, Landau JM, Vergilis-Kalner IJ, Goldberg LH, Friedman PM, Bruce S (2011) Laser eradication of pigmented lesions:a review. Dermatol Surg 37:572–595
Hruza GJ, Dover JS, Flotte TJ, Goetschkes M, Watanabe S, Anderson RR (1991) Q-switched ruby laser irradiation of normal human skin. Histologic and ultrastructural findings. Arch Dermatol 127:1799–1805
Okazaki M, Yoshimura K, Suzuki Y, Uchida G, Kitano Y, Harii K, Imokawa G (2003) The mechanism of epidermal hyperpigmentation in cafe-au-lait macules of neurofibromatosis type 1 (von Recklinghausen’s disease) may be associated with dermal fibroblast-derived stem cell factor and hepatocyte growth factor. Br J Dermatol 148:689–697
Okazaki M, Yoshimura K, Uchida G, Suzuki Y, Kitano Y, Harii K (2005) Epidermal hyperpigmentation in non-syndromic solitary cafe-au-lait macules may be associated with increased secretion of endothelin-1 by lesional keratinocytes. Scand J Plast Reconstr Surg Hand Surg 39:213–217
Torres-Alvarez B, Mesa-Garza IG, Castanedo-Cazares JP, Fuentes-Ahumada C, Oros-Ovalle C, Navarrete-Solis J et al (2011) Histochemical and immunohistochemical study in melasma:evidence of damage in the basal membrane. Am J Dermatopathol 33:291–295
Jeong SY, Shin JB, Yeo UC, Kim WS, Kim IH (2010) Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream. Dermatol Surg 36:909–918
Mun JY, Jeong SY, Kim JH, Han SS, Kim IH (2011) A low fluenceQ-switched Nd:YAG laser modifies the 3D structure ofmelanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. J Electron Microsc 60:11–18
Herd RM, Dover JS, Arndt KA (1997) Basic laser principles. Dermatol Clin 15(3):355–372
Wattanakrai P, Mornchan R, Eimpunth S (2010) Low-fluence Qswitched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg 36(1):76–87
Polnikorn N (2008) Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports. J Cosmet Laser Ther 10(3):167–173
Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH (2010) A case series of facial depigmentation associated with low fluence Q switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. Lasers Surg Med 42(8):712–719
Kim BW, Lee MH, Chang SE, Yun WJ, Won CH, Lee MW et al (2013) Clinical efficacy of the dualpulsed Q-switched neodymium:yttrium-aluminum-garnet laser: comparison with conservative mode. J Cosmet Laser Ther 15(6):340–341
Kagami S, Asahina A, Watanabe R, Mimura Y, Shirai A, Hattori N, Watanabe T, Tamaki K (2007) Treatment of 153 Japanese patients with Q-switched alexandrite laser. Lasers Med Sci 22(3):159–163
Alora MB, Arndt KA (2001) Treatment of a cafe-au-lait macule with the erbium: YAG laser. J Am Acad Dermatol 45:566–568
Acknowledgments
We thank the patients and their families for their ongoing participation in this study. Their understanding was important in ensuring the success of this important clinic trial.
Funding
This publication presents independent research funded by the most important clinical discipline in Shanghai (2017ZZ2026-02), National Nature Science Foundation of China (81630083). There was no commercial support for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was carried out in accordance with the Declaration of Helsinki, approved by Xinhua Hospital Ethics Committee Affiliated to Shanghai Jiaotong University School of Medicine (XHEC-D-2019-108). All patients signed informed consent before participating in the study.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(XLS 34 kb)
Rights and permissions
About this article
Cite this article
Zhuang, Y., Huang, M., Shen, J. et al. Comparison of the efficacy and safety between a low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser and a conventional Q-switched 532-nm laser for the treatment of cafe-au-lait macules in 40 Chinese children: a prospective, randomized, parallel-controlled, evaluator-blinded trial. Lasers Med Sci 37, 279–286 (2022). https://doi.org/10.1007/s10103-021-03245-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-021-03245-w